Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synergistic integration of ripple filter and penumbra reduction for enhanced dose conformity and beam delivery efficiency in proton therapy.

Created on 24 Jun 2026

Authors

Lijia Zhang, Nicki Schlegel, Rongcheng Han, Yinxiangzi Sheng

Published in

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). Volume 148. Pages 105865. Jun 23, 2026. Epub Jun 23, 2026.

Abstract

This study evaluates the synergistic integration of Ripple Filter (RiFi) and Extended Penumbra Reduction (EPR) techniques, which reposition the patient closer to the nozzle, to enhance dose distribution and beam delivery efficiency in head and neck cancer patients.
A retrospective analysis was performed on 30 patients with head and neck and intracranial tumors treated at SPHIC from 2023 to 2024. Three treatment planning strategies were compared: No-RiFi, EPR20+RiFi (20 cm forward shift), and EPR40+RiFi. Dosimetric parameters, including target coverage, homogeneity index (HI), conformity index (CI), and organ-at-risk (OAR) doses, were evaluated. In addition, energy layer counts and beam delivery time were compared.
The EPR+RiFi plans demonstrated non-inferior target coverage compared with the No-RiFi plans. With the exception of the maximum spinal cord dose, the EPR20+RiFi plans resulted in higher OAR doses compared with the No-RiFi plan, with mean differences within 0.5 Gy(RBE). In contrast, the EPR40+RiFi plans showed small dose reductions in most OARs (mean decrease 0.1-1.1 Gy(RBE)). Notably, the integration of RiFi with EPR significantly reduced the number of energy layers and shortened beam delivery time by an average of 54% (ranging from 46% to 60%).
The combined use of RiFi and EPR with a 40 cm forward shift significantly enhances beam delivery efficiency while maintaining or reducing OAR doses. These findings support the clinical feasibility of this approach and its potential to improve treatment capacity in high-volume proton therapy centers.

PMID:
42335517
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement